Ronald Kirk Huntsman
Chief Executive Officer at Vivos Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Vivos Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Vivos Therapeutics Inc. November 4, 202593.0%
-
Vivos Therapeutics Inc. September 25, 202366.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Vivos Therapeutics Inc. | Other | +85,910 | $0.58 | $50,000 |
| Jun 20, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +14,000 | $0.53 | $7,420 |
| Jun 16, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +10,000 | $0.54 | $5,400 |
| Jun 16, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +5,000 | $0.53 | $2,650 |
| Jun 15, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +21 | $0.50 | $11 |
| Jun 14, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +10,000 | $0.49 | $4,900 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.